SCHEMBL30962827

SCHEMBL30962827

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)ncc1C(=O)Nc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 6/20 0.52
▸ TTK P33981 1/20 0.49
▸ WEE1 P30291 1/20 0.48
▸ KDR P35968 4/20 0.48
▸ MAPK14 Q16539 4/20 0.48
▸ JAK3 P52333 1/20 0.48
▸ TEK Q02763 1/20 0.48
▸ ITK Q08881 2/20 0.47
▸ ALK Q9UM73 1/20 0.47
▸ SIK1 P57059 2/20 0.46
▸ SIK2 Q9H0K1 2/20 0.46
▸ SIK3 Q9Y2K2 2/20 0.46
▸ TNK2 Q07912 1/20 0.45
▸ STAT6 P42226 1/20 0.44
▸ BRD4 O60885 2/20 0.43
▸ FGFR3 P22607 1/20 0.43
▸ CCNT1 O60563 1/20 0.42
▸ CCNE1 P24864 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ CDK9 P50750 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962770 0.90 LCK (0.51) LCKTTKWEE1KDRMAPK14
SCHEMBL27313423 0.90 LCK (0.51) LCKTTKWEE1KDRMAPK14
SCHEMBL30962624 0.90 WEE1 (0.52) LCKWEE1KDRMAPK14JAK3
SCHEMBL27313552 0.90 WEE1 (0.52) LCKWEE1KDRMAPK14JAK3
SCHEMBL27313416 0.89 WEE1 (0.54) LCKWEE1KDRMAPK14JAK3
SCHEMBL30962865 0.88 SIK1 (0.50) LCKTTKWEE1KDRMAPK14
SCHEMBL30962699 0.88 SRC (0.53) LCKWEE1KDRMAPK14JAK3
SCHEMBL27313419 0.88 SRC (0.53) LCKWEE1KDRMAPK14JAK3
SCHEMBL27313548 0.88 SIK1 (0.50) LCKTTKWEE1KDRMAPK14
SCHEMBL30962850 0.88 SIK1 (0.48) LCKTTKWEE1KDRMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback